Back to results

Massachusetts Institute of Technology

Design of a large-dose minimally invasive drug delivery device for Tuberculosis

Abstract

dc:description.abstract

Tuberculosis (TB) affects millions of people all over the world, and in India has an incidence figure of about 2.8 million individuals annually. The TB treatment regime is quite involved, generally requiring six months and multiple medications. A lack of medication adherence can lead to drug-resistant TB. One current method to improve adherence requires the medicine to be dispensed multiple times a week at directly observed treatment (DOT) clinics, a practice which is neither convenient for patients nor completely effective for purposes of adherence. A suite of technologies is being developed to introduce a large-dose drug delivery device into the gastrointestinal (GI) tract. This device would release a discrete amount of drugs every day over the course of a month. The device would be deployed into the stomach through a short-term nasogastric tube placement, and the device would be removed and replaced with a new device after one month. The medication required for a month of treatment can be transferred into a drug delivery device in the stomach via a standard nasogastric tube. Testing conducted on this medication transportation process has showed that 1 month's worth of medication can be placed into a device in the stomach in 7 minutes. In addition to device design, a series of questionnaires are being implemented to ask TB doctors and patients about the feasibility and acceptability of short-term nasogastric tube usage for TB treatment. This device and treatment method has the potential to assist in eradicating TB and allow millions more convenient and effective TB treatment.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Mechanical Engineering.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Leibowitz, Dalia
Advisor dc:contributor.advisor
  • Alexander Slocum.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/118021
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/118021

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Leibowitz, Dalia. Design of a large-dose minimally invasive drug delivery device for Tuberculosis. Massachusetts Institute of Technology, 2018. http://hdl.handle.net/1721.1/118021